908 Devices announced the critical role of its MX908 – a handheld, battery-powered, mass spectrometry device – for the Ohio Attorney General Bureau of Criminal Investigation (BCI) and the Ohio Organized Crime Investigations Commission (OOCIC). The MX908 provides reliable investigative information in the field with rapid analysis of suspected narcotics and limits officer exposure risk to the dangers of synthetic opioids. Ohio is often referenced as ‘ground zero’ for the nation’s opioid crisis, having among the highest rates of drug overdose deaths involving opioids in the U.S. The last few years have seen the emergence of carfentanyl, a synthetic opioid 10,000 times more potent than morphine and 100 times more potent than fentanyl, further increasing the threat to communities and law enforcement. The CDC estimates that the U.S. will suffer more than 75,500 drug-related deaths in 2020 alone, which would set a record for a second year in a row. MX908 provides investigators the ability to quickly and reliably detect and identify a broad range of fentanyls, opioids and amphetamines with high confidence, and at trace levels, which drastically minimize exposure to risk. The data-based evidence also allows officers to move forward with charges that were not previously possible with other field techniques.